| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 7.588 | 14.128 | 18.951 | 20.896 | 22.921 |
| Total Income - EUR | - | - | - | - | - | 7.588 | 14.128 | 22.297 | 21.057 | 22.921 |
| Total Expenses - EUR | - | - | - | - | - | 5.931 | 7.630 | 10.247 | 21.189 | 26.960 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 1.657 | 6.498 | 12.050 | -132 | -4.040 |
| Net Profit/Loss - EUR | - | - | - | - | - | 1.444 | 6.074 | 11.587 | -341 | -4.727 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Oprisor Healthcare Group S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 22.120 | 15.437 | 8.772 |
| Current Assets | - | - | - | - | - | 3.679 | 9.718 | 4.559 | 6.639 | 7.544 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 0 | 0 | 5.468 |
| Cash | - | - | - | - | - | 3.679 | 9.718 | 4.559 | 6.639 | 2.076 |
| Shareholders Funds | - | - | - | - | - | 1.485 | 7.526 | 14.867 | 14.481 | 9.673 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 2.193 | 2.192 | 11.812 | 7.595 | 6.644 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Oprisor Healthcare Group S.r.l.